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Abstract 
 
Objective: To systematically investigate causal relationships between obesity and 
cerebrovascular disease, and the extent to which hypertension and hyperglycemia 
mediate the effect of obesity on cerebrovascular disease. 
Methods: We used summary statistics from genome-wide association studies for body 
mass index (BMI), waist-to-hip ratio (WHR) and multiple cerebrovascular disease 
phenotypes. We explored causal associations with two-sample Mendelian 
randomization (MR) accounting for genetic covariation between BMI and WHR; and 
assessed what proportion of the association between obesity and cerebrovascular 
disease was mediated by systolic blood pressure (SBP) and blood glucose levels 
respectively. 
Results: Genetic predisposition to higher BMI did not increase the risk of 
cerebrovascular disease. In contrast, for each 10% increase in WHR there was a 75% 
increase (95% confidence interval (CI)=44%-113%) in risk for large artery ischemic 
stroke, a 57% (CI=29%-91%) increase in risk for small vessel ischemic stroke, a 
197% increase (CI=59%-457%) in risk of intracerebral hemorrhage, as well as an 
increase in white matter hyperintensity volume (β=0.11; CI=0.01-0.21). These WHR 
associations persisted after adjusting for genetic determinants of BMI. Approximately 
one tenth of the observed effect of WHR was mediated by SBP for ischemic stroke 
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Interpretation: Abdominal adiposity may trigger causal pathological processes, 
partially independent from blood pressure and totally independent from glucose 
levels, that lead to cerebrovascular disease. Potential targets of these pathological 
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Introduction: 
 
Deaths related to stroke across all ages have seen an increase of 22% in the last 
decade
1
. Novel therapeutic targets are needed, and their discovery could be 
propelled by clarification of causal pathways. Observational studies have shown 
that obese individuals experience roughly double the risk for stroke compared to 
those of normal weight
2
. Whether this association is causal or a proxy for 
unmeasured lifestyle factors or covarying health exposures remains unclear. For 
instance, prior studies have shown that body mass index (BMI) is not associated 
with stroke risk after adjusting for known vascular risk factors
3
. Observational 
analyses intending to separate the inherent risk conferred by adiposity from the 
effect of covarying mediators (such as hypertension) may suffer from 
confounding and underestimation of true effects
4
.  
Mendelian randomization (MR) is an instrumental variable analysis approach that 
has been deployed in genetic epidemiology to determine whether associations of 
co-occurring traits reflect a causal relationship or simple correlation
5
. Two 
previous analyses applied MR to show that central adiposity increases risk of 
ischemic stroke, among other cardiovascular phenotypes
6,7
. Leveraging the most 
updated genome-wide association study (GWAS) data for body fat distribution 
and obesity, stroke, and additional cerebrovascular disease traits, we aimed to: (i) 
determine the degree to which different cerebrovascular disease subtypes are 
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or BMI) best explains any increase risk of stroke; and (iii) assess the role of 




Traits analyzed and genome-wide association studies 
Publicly available GWAS summary meta-analysis statistics were obtained for 
BMI and WHR, and for intracerebral hemorrhage (ICH), white matter 
hyperintensity (WMH) volume and ischemic stroke. Genetic association results 
for BMI and WHR were derived from the largest currently available meta-
analysis of European ancestry individuals
8
. Briefly, we used summary-level 
genotype data of both sexes from the UK Biobank and the GIANT consortium, 
which tested genome-wide associations for WHR and BMI in 694,649 subjects. 
Phenotypes were adjusted for sex, age and recruitment center and underwent 
center rank inverse normalization.  Ischemic stroke was analyzed in toto (all-cause 
ischemic strokes) and further as subclassified into large-artery atherosclerotic 
stroke (LAS), cardioembolic stroke (CES), and small-vessel stroke (SVS)
9
. ICH 
was subclassified into lobar and non-lobar ICH, given the different 
pathophysiology by location
10
. Genetic data for ischemic stroke (including the 
etiological subtypes) and for ICH were derived from the MEGASTROKE 
consortium
9
 and the International Stroke Genetic Consortium (ISGC) GWAS for 
ICH
11
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meta-analysis restricted to subjects of European ancestry after adjusting for age, 
sex and principal components reflecting ancestry (40,585 cases; 406,111 
controls). To extend the spectrum of cerebrovascular disease phenotypes, we also 
analyzed WMH volume (in mm
3
), a known magnetic resonance imaging (MRI) 
biomarker of cerebral small vessel disease
12
. We used GWAS summary statistics 




Systolic blood pressure (SBP) and fasting blood glucose (FG) were identified as 
possible mediators of obesity, based on previous literature demonstrating 
hypertension and diabetes as being affected by obesity while conferring risk for 
stroke
6,14,15
. Although abnormal cholesterol and triglyceride levels are also 
associated with obesity, given inconsistent and sometimes diverging risk 
associations between lipid levels and stroke risk, we chose to limit mediation 
analysis to SBP and FG
16
.  We prioritized the continuous traits of FG and 
hemoglobin A1c (HbA1c) over diabetes case/control status, as dichotomous 
exposure variables can introduce bias into MR analyses related to violation of the 
monotonicity assumption, as the variants employed as instruments will not predict 
the exposure phenotype in all individuals
17
. Compared to HbA1c, FG is less 
affected by erythrocyte lifespan in non-diabetic participants
18
 and is informed by a 
more powered GWAS. FG was therefore selected for the primary analysis while 
HbA1c was included for confirmation. SBP genetic association data were derived 
from the UK Biobank. Specifics of the analysis have been detailed elsewhere
19
. 
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summary level GWAS data for SBP corrected for the effects of anti-hypertensive 
treatment. European ancestry-specific genome-wide meta-analysis summary 
statistics for association with HbA1c and FG were available through the latest 
effort of the Meta-Analyses of Glucose and Insulin-related traits Consortium 
(MAGIC, www.magicinvestigators.org)
20,21
. Genotyping and bioinformatic 
genetic analysis of each of these GWAS followed standardized procedures that 
are harmonized and comparable across the studies. Detailed genotype and 
phenotype assessment procedures are available in the studies referred
8-9,11,19-21
. 
Additional demographic and phenotypic information on the included studies is 
available in Table 1. 
Statistical Analysis: 
Overall, we used three genetic instruments for our exposures of interest including, 
BMI, WHR and WHR adjusted for BMI (WHRadj), tested against 
cerebrovascular disease outcomes. Association estimates for BMI, WHR and 
outcomes were extracted from the above-mentioned studies, harmonized by risk 
allele, and used in the MR analyses with the association estimates between the 
instruments and the described outcomes. The included instruments were single-
nucleotide polymorphisms (SNPs) pruned at r
2
 <0.01 based on the European 
1000-Genomes reference panel, that demonstrated association with BMI and 
WHR, individually, at genome-wide significance (p<510
-8
).   
WHRadj was derived from BMI and WHR. Since BMI is a correlated covariate of 
WHR, collider bias may be present when using summary statistic data from 
GWAS of WHR adjusted for BMI
22
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multivariable mendelian randomization model
23
, using WHR as a predictor and 
BMI as a covariate.  
Mendelian Randomization Analyses:  
Complementary MR approaches were applied. We first used the inverse variance–
weighted (IVW) method
24
. Heterogeneity across estimates was assessed using I
2
 
and Cochran’s Q (p<0.05 and I
2
>50% were considered statistically significant)
25
.  
Then, we used the weighted median estimator
26
, a method that can provide valid 
estimates if at least 50% of the information in the analysis comes from SNPs that 
are valid instrumental variables,
26
 and MR-Egger regression
27
, generally 
considered to be conservative in the presence of pleiotropic variants and less 
likely to generate inflated test statistics leading to false positive associations
28
. As 
a further sensitivity analysis, we also performed the weighted mode-based 
estimation method, which provides strongest estimates when the most common 
causal effect estimate is a consistent estimate of the true causal effect, even if the 
majority of instruments are invalid
29
. We applied the Benjamini-Hochberg 
procedure for controlling the false positive rate in multiple comparisons. Finally, 
when significant MR results between traits were found, we used (i) MR-
PRESSO
30
, to explore presence of outliers that could bias the results, and (ii) 
bidirectional MR, to test for any inverse associations using obesity traits as 
outcomes and cerebrovascular disease phenotypes as exposures
31
.  In our 
bidirectional MR we pruned at r
2
 <0.5 using SNPs associated with 
cerebrovascular disease at genome-wide significance. The higher r
2
 threshold for 
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associated with cerebrovascular disease. We also adjusted for genetic correlation 
(based on 1000 Genomes Project CEU population) between instruments by 
weighting for the inverse LD correlation matrix. 
Mediation analysis: 
For the mediation analysis, we performed conventional network MR
32
. 
Specifically, we first estimated the effect of BMI/WHR on each respective 
mediator (SBP and FG) using the IVW MR approach. Next, we applied 
regression-based multivariable MR to estimate the effect of SBP and FG 
respectively on risk of stroke and its subtypes, adjusting for the genetic effect of 
the instruments on BMI or WHR respectively
27
. The indirect effect of the 
considered exposure on stroke risk mediated through SBP or FG was estimated by 
multiplying results from these two MR analyses. We finally divided the mediated 
effect by the total effect to estimate the proportion mediated, as previously 
done
19,32
. The above-described method was applied to HbA1c as well.  
 
Analysis was performed using R version 3.4.3 (The R Foundation for Statistical 
Computing) together with the R packages gtx and MR-PRESSO
30
. The list of 
genetic variants used appear in Supplemental Table 1. This study used publicly 
available deidentified data from participating studies that had already obtained 
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BMI and WHR and cerebrovascular traits 
Our first MR approach (IVW-MR) suggested that increased BMI is significantly 
associated with increased risk of all cerebrovascular traits. This association 
appeared to be affected by significant heterogeneity as defined by Cochran’s Q 
between SNPs (Supplemental Table 2). Similar findings were observed when 
testing for associations between WHR and cerebrovascular disease. Given 
concern that pleiotropy may have been contributing to an inflation in association 
statistics and thus potentially undermining the true causality of the observed 
relationships, we turned to additional, more conservative MR approaches: 
Weighted Median MR and Egger regression. 
The Weighted Median MR found that each 4.81 kg/m
2
 increase in BMI was 
associated with a modest 0.12 mm
3
 increase in WMH volume (β=0.12; 95% 
Confidence Intervals (CI)= 0.04-0.20; p=6.0010
-3
). However, none of the 
remaining cerebrovascular disease traits were found to be causally affected by 
BMI using the Weighted Median approach. Egger regression testing for a causal 
relationship between BMI and WMH was not significant (β=0.04; CI=-0.06-0.14; 
p=0.742; Egger intercept p=0.068) (Figure 1A).  
In contrast, findings related to WHR largely retained significance using these 
conservative MR approaches. Weighted Median MR analyses showed genetically-
determined higher WHR to be associated with an increased risk of all-cause 
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deviation increase in WHR of 0.09 (9% increase in WHR absolute, 10% relative 
to the mean) corresponding to an increase in LAS and SVS by 75% and 57%, 
respectively. Genetically-determined higher WHR also increased the risk of non-
lobar ICH and WMH; the same 9% increase in WHR increased non-lobar ICH 
risk by 197% and WMH volume by 0.11 mm
3
. No associations were found for 
CES or lobar ICH (Figure 1B). Reassuringly, the Egger regression approach was 
concordant with the Weighted Median MR results for the causal relationship 
between WHR and all stroke (Odds Ratio (OR)=1.31; CI=1.10-1.56; p=0.018; 
Egger intercept p=0.892), LAS (OR=1.63; CI=1.04-2.56; p=0.045; Egger 
intercept p=0.776) and SVS (OR=1.58; CI=1.05-2.39; p=0.045; Egger intercept 
p=0.923). For non-lobar ICH and WMH, Egger regression analysis testing the 
causal effect of WHR returned similar effect size estimates to the Weighted 
Median MR approach but they were not statistically significant (non-lobar ICH: 
OR=3.10; CI=0.67-14.28; p=0.168; Egger intercept p=0.903; WMH: β=0.17; CI= 
-0.02-0.35; p=0.117; Egger intercept p=0.663). 
Sensitivity analyses 
As a further test of the robustness of our findings across MR methodologies, 
weighted Mode-based MR analysis showed consistent effect sizes and directions 
to those from the primary Weighted Median MR (Supplemental Table 2). MR-
PRESSO did not identify any outliers and further supported a lack of bias related 
to pleiotropy between WHR and all-cause ischemic stroke, LAS and SVS 
(Supplemental Table 2). When applying bidirectional MR, we found no 
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WHR (Supplemental Table 3), supporting our modeling assumption that genetic 
determinants of stroke risk are unlikely to causally influence WHR. 
WHR adjusted for BMI 
Multivariable MR demonstrated that WHR causally influenced cerebrovascular 
risk even after controlling for BMI. An increase in WHR (1 standard deviation, 
9% absolute or 10% relative increase from the mean) adjusted for BMI was 
independently associated with all-cause ischemic stroke (OR=1.25; CI=1.15-1.35; 
p=1.1210
-6
); LAS (OR=1.72; CI=1.38-2.13; p=1.2410
-6
), SVS (OR=1.93; 
CI=1.59-2.35; p=3.8010
-10
); non-lobar ICH (OR=2.78; CI=1.34-5.78; p=6.010
-
3
) and WMH (β= 0.10; CI=0.08-0.28; p=3.7910
-4
), but not with CES or lobar 
ICH, supporting the results of our univariate MR models for WHR.  
Mediation analysis  
The effect of WHR was partially mediated by SBP for all-cause ischemic stroke 
(proportion mediated: 12%; CI=4%-20%; p=5.010
-3
); LAS (proportion 
mediated: 13%; CI=2%-25%; p=0.03); and SVS (proportion mediated: 11%; 
CI=1%-21%; p=0.04). We did not find a significant mediation effect for non-lobar 
ICH (proportion mediated: 9%; CI=-5%-23%; p=0.235) and WMH (proportion 
mediated: 12%; CI=-7%-31%; p=0.210) (Figure 2).  Mediation analyses for the 
effect of FG on WHR-mediated risk did not show significant effects for all-cause 
ischemic stroke (proportion mediated: 0%; CI=-38%-16%; p=0.430); LAS 
(proportion mediated: 3%; CI=-22%-29%; p=0.810); SVS (proportion mediated: 
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20%-22%; p=0.909) or WMH (proportion mediated: 0%; CI=0%-100%; 
p=0.840). Similar results were found when testing HbA1c instead of FG. 
Although the weighted median MR approach identified a potential causal effect for 
BMI on WMH volumes alone, and at a smaller effect size than what has been 
observed in association with clinical outcomes, in the interest of completeness we also 
explored mediating factors for any effect of genetically-determined BMI (as an 
exposure) on cerebrovascular disease. SBP significantly mediated a considerable part 
of the putative association between BMI and all-cause ischemic stroke, LAS and SVS 
(Figure 2). FG and HbA1c did not mediate BMI risk on any tested cerebrovascular 
phenotypes (Supplemental Table 4). 
 
Discussion: 
Leveraging GWAS summary data, our study confirms a causal relationship 
between obesity and cerebrovascular disease, relates it primarily to abdominal 
adiposity and specific cerebrovascular phenotypes, and clarifies a possible role for 
mediation through hypertension but not hyperglycemia.  
Several previous observational studies have investigated the association between 
obesity and risk of ischemic strokes
34–36
. Both previous MR analyses
6,7
 suggested 
that obesity, but not BMI, could be causal in this relationship, showing an overall 
30% increased risk for ischemic stroke for each standard deviation increase in 
abdominal adiposity
6
. However, the studies failed to confirm the association when 
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did not resolve which ischemic stroke subtypes are specifically affected by 
abdominal adiposity. Our analyses, leveraging greater statistical power enabled by 
the latest consortia efforts, are able to confirm these results with MR approaches 
more robust to the presence of pleiotropic instruments
28
, suggesting that higher 
abdominal adiposity intrinsically increases risk of ischemic stroke. Our study also 
confirms the lack of a robust causal effect for BMI across ischemic stroke and its 
subtypes. As has been previously suggested, BMI ignores important health-
determinants such as muscle mass and distribution of adiposity, and may therefore 
be a relatively poor biological tool for examination of causal pathways in 
disease
37,38
. Our results suggest that WHR specifically increases stroke risk, and 
this effect persists even after adjustment for BMI.  Given that studies with direct 
assessments of body adiposity showed that WHR adjusted for BMI is a surrogate 
measure of abdominal adiposity
39
 our results specifically implicate abdominal 
distribution of fat in a causal process leading to cerebrovascular disease.  
Two prior genetic studies have investigated the relationship between obesity and 
ICH and did not identify any significant associations
6,7
. To our knowledge, no 
study has investigated distinct effects between lobar and non-lobar ICH. In 
contrast to ischemic stroke, epidemiologic studies have reported conflicting 
results on the association between obesity and ICH risk, with one study reporting 
an increased prevalence of obesity in patients hospitalized for ICH
40
, and another 
showing that ICH cases have lower BMI
41
.  In another multicenter study, BMI 
increased the risk of non-lobar ICH but only through an indirect effect of 
hypertension
42
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lobar ICH alone, with no contribution to risk of lobar ICH. Although we cannot 
fully exclude horizontal pleiotropy in this situation, all the employed MR 
approaches, which make distinct assumptions on the presence of any pleiotropic 
variants, returned consistent results. Finally, studying the effect of adiposity on 
white matter lesions, we found that even if genetic susceptibility for higher BMI 
and WHR are statistically associated with more severe WMH, the overall effect is 
negligible and is unlikely to be clinically impactful. Given the common small 
vessel pathology shared between non-lobar ICH, SVS, and WMH
12
, it may be 
reasonable to hypothesize that abdominal adiposity may prompt pathological 
mechanisms that also lead to WMH. Deployment of higher power GWAS of 
WMH in healthy subjects or use of WMH GWAS data from subjects affected by 
cerebrovascular disease may yield different results.  
Research has suggested several pathological cascades arising from obesity that 
lead to thrombosis and cardiovascular disease. The most intuitive are represented 
by increased blood pressure and diabetes, two recognized causal factors for 
arteriosclerosis of large and small blood vessels
12
. Compared to mediation 
analysis based on observational data, MR is less susceptible to measurement 
error
19
 and therefore offers favorable opportunities for understanding any 
mediation by hypertension and hyperglycemia in obesity. Our mediation results 
suggest that causal mechanisms arising from abdominal fat distribution contribute 
to cerebrovascular disease largely independent of these factors. Along with 
metabolic derangements, obesity is associated with significant and protracted 










This article is protected by copyright. All rights reserved.
grade chronic inflammatory state
43
. Low grade inflammation and systemic 
oxidative stress have proven to be damaging for the endothelium, shifting it 
towards a prothrombotic state. Platelet reactivity, enhanced coagulation and 
impaired fibrinolysis are other recognized mechanisms
44
. Our results 
demonstrating increased risk for SVS and non-lobar ICH on one hand, and for 
LAS on the other suggest that both cerebral microvascular disruption and 
accelerated atherosclerosis leading to stroke may be triggered by obesity.  
Our MR benefits from multiple and orthogonal approaches. Although results from 
different approach were comparable in direction and effect size, association 
results from IVW-MR appeared to be inflated and affected by pleiotropy. 
Therefore, we focused on the more conservative and selective approach of 
Weighted Median and Egger regression, more robust to the inclusion of 
pleiotropic variants. Mode-based results were also consistent but produced less 
precise estimates and wider confidence intervals, perhaps reflecting a poorer 
model-fit for modal assumptions.  
Our study has several limitations. Although we have used multiple MR 
approaches to guard against confounding due to pleiotropy, we cannot fully 
exclude residual bias, which is an established limitation of the MR approach
45
. 
Similarly, we attempted to limit the misleading inferences introduced by trait 
heterogeneity by applying multivariable MR. Well-powered studies with 
individual level data on the included small vessel phenotypes in addition to 
measured BMI and WHR values will ultimately be required in order to confirm 
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limited to individuals of European ancestry and as such our results cannot 
necessarily be generalized to other ancestral populations. This is particularly 
relevant given the known disparities in obesity and stroke risk in traditionally 
underserved populations such as blacks and Hispanics
46
. Future studies building 
on our approach in diverse populations are needed to extend our findings. We did 
not include genetic predisposition to lipid blood levels as a mediator of the 
relationship between obesity and cerebrovascular disease, given that lipid effects 
on cerebrovascular outcomes are unsettled and potentially opposing in effects 
across ischemic and hemorrhagic stroke. Although triglyceride and cholesterol 
levels are related to central obesity, associations between cholesterol levels and 
increased risk of stroke lack the consistency of studies on hypertension and 
diabetes,
47
 and associations in ICH are even more unclear
48
. As such, the results 
of a lipid mediation analysis would be difficult to interpret. Lastly, individual 
level data were not available; this precluded us from extending our analysis to 
sex-specific effects of obesity. However, previous observations showed that 






Our study identifies abdominal adiposity as a causal risk factor for 
cerebrovascular disease, demonstrates differential effects across stroke subtypes, 
and suggests a substantial proportion of this effect extends beyond hypertension 
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central obesity as potential therapeutic candidates for stroke
49
. The importance of 













This article is protected by copyright. All rights reserved.
 
Acknowledgements: 
This study was supported by the following awards from the NIH:  K23NS086873, 
R01NS103924, R01NS093870. Dr. Marini is supported by the American Heart 
Association/American Stroke Association fellowship (18POST34080063). Dr. 
Merino has received funding from the European Union’s Horizon 2020 research 
and innovation programme under the Marie Skłodowska-Curie grant agreement 
#703787. Dr. Florez is supported by NIDDK K24 DK110550. Dr. Anderson 
receives sponsored research support from the American Heart Association and 
Bayer AG, and has consulted for ApoPharma, Inc. Dr. Rosand reports grants from 




Conception and design of the study: CDA, DG, JM, SM. 
Acquisition and analysis of data: DG, BEM, JM, RM, SM, CLS. 
Drafting a significant portion of the manuscript or figures: CDA, DG, JCF, BEM, 
SM, MD, JR. 
 











This article is protected by copyright. All rights reserved.
Figure Captions 
 
Figure 1:  Mendelian randomization associations of genetically determined BMI 
and WHR with cerebrovascular disease. Results derived from weighted median 
Mendelian Randomization analysis (Odds Ratio and 95% Confidence intervals for 
each 6% increment in BMI and 9% increment in WHR, corresponding to one 
standard deviation in each) are shown. 
Legend: BMI: body mass index; WHR: waist hip ratio; WMH: white matter 
hyperintensity; ICH: intracerebral hemorrhage; LAS: large artery stroke; SVS: 
small vessel stroke; CES: cardio embolic stroke.  
 
Figure 2:  Mediation analysis: estimates for the SBP mediating the effect of WHR and 
BMI on cerebrovascular disease outcomes. For any cerebrovascular disease, we report 
the average proportion mediated (dot), the 95% confidence intervals of the percentage 
mediated (grey bar) and p value.  
Legend: BMI: body mass index; WHR: waist hip ratio; WMH: white matter 
hyperintensity; ICH: intracerebral hemorrhage; LAS: large artery stroke; SVS: 
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Table 1: Characteristics of subjects included in the GWAS studies utilized for the analyses.
Legend: BMI: Body Mass Index; WHR: Waist Hip Ratio; IS: Ischemic Stroke; LAS: Large Artery Stroke; CES: Cardioembolic Stroke; SVS: Small-Vessel 
Stroke; ICH: Intracerebral Hemorrhage, WMH: White Matter Hyperintensity; FG: fasting glucose; HbA1c: hemoglobin A1c
TRAIT CONSORTIUM Subjects Women (%) mean age (SD) Trait mean value (SD)
BMI 806,834 54 NA 27.41 (4.81)Obesity traits
WHR
UKBiobank+GIANT
697,734 55 NA 0.87 (0.09)
cases
IS 10,307 41.7 67.4 (12.3)
LAS 3,808 48.9 65.9 (10.4)
CES 3,697 46.4 68.1 (9.4)
SVS
MEGASTROKE
2,206 45.5 65.6 (12.4)
ICH ISGC 1,545 45.1 67.0 (10)
Cerebrovascular disease 
phenotypes 
WMH UK-Biobank 10,597 52.7 54.9 (7.5) 4,607 (6,021) mm3
Mediation analysis traits FG MAGIC 133,010 46.3 50.1 (18.4) 5.33 (0.44) mmol/l
HbA1c                    MAGIC 123,665 51.37 53.8 (10.3) 5.38 (0.22) %
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